Newly released data in Fact.MR’s market analysis shows that demand for diet pills in Europe is expected to increase at a CAGR of 2.6% through 2031, with the market being valued at US$ 669 Mn currently.
Sales of glucomannan drugs are expected to grow from US$ 258.1 Mn in 2020 to around US$ 361.2 Mn by 2031, while those of herbal supplements from US$ 455.1 Mn to around US$ 611.6 Mn.
Detailed Insights Offered in Europe Diet Pills Industry Survey:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Sales of Diet Pills in 2020 and Beyond and How to Navigate
- Recommendation on Key Winning Strategies
Know More Details About the Report
Sales Analysis of Diet Pills in Europe from 2016 to 2020 Vs Market Outlook for 2021 to 2031
Market growth in terms of CAGR from 2016 to 2020 for diet pills in Europe has been observed a 0.7%, wherein, glucomannan had the highest market share of 39.5%in 2020.
More number of customers are inclining towards dietary supplements such as diet pills in their daily dietary habits. Moreover, customers across the U.K. and Germany, where cases of obesity are rising at a fast pace, are adopting preventive measures and focusing on the consumption of dietary supplements.
Increasing health awareness among customers and rising willingness to spend on dietary supplements and nutrition are driving demand for diet pills as an appetite suppressant across the continent. Additionally, development of distribution channels for diet pills is leading to better accessibility, which is also expected to boost market growth.
In addition, growing geriatric population and rising healthcare costs throughout Europe are anticipated to support the market in gaining significant traction over the coming years.
Considering these statistics and shift in dynamics for demand for diet pills as a fat blocker, over the forecast period of 2021-2031, the market is expected to expand at around 2.6% CAGR.
What are the Key Opportunities Ahead for European Diet Pill Manufacturers?
Opportunity for key players for increased sales of fat blocker diet pills exists with rising awareness. Manufacturers involved in the development of diet pills are focusing on the development of highly advanced medicines that can satisfy end users. Most studies reveal that people who want to look and feel healthier seek more options in addition to just diet and exercise.
Increasing prevalence of cardiovascular diseases, rising cholesterol levels, and surging lifestyle diseases are also some of the key factors that are contributing to the increase in the number of consumers looking for weight loss supplements, thereby complementing the sales of diet pills for appetite control.
Avail customized purchase options for your needs
What is the Main Restraining Factor for Diet Pill Suppliers in Europe?
Higher cost involved in drug development of prescription obesity drugs is a great challenge for manufacturers of diet pills. Moreover, prolonged time required for drug development activities and also need for intensive clinical trials to test drugs add to the expenditure.
Thus, manufacturers of metabolism raising diet pills must stay cautious and ensure investments in markets that can provide better return on investments. Restrictions posed by higher R&D of obesity drugs will hinder market growth to some extent.
Limited availability of approved drugs has resulted in large-scale adoption of off-label drugs, which means, prescribed class of drugs are effective in the treatment of obesity but not approved by regulatory authorities as an actual drug to treat the condition. Thus, widespread adoption of off-label drugs limits the penetration of actual drugs, subsequently restraining market.
How is Increasing Prevalence of Obesity and Associated Comorbidities Impacting Demand for Diet Pills for Appetite Suppression?
Growing incidence of obesity is a major challenge to disease prevention across the globe. It is estimated that obesity is a major public health problem in Europe. For instance, in 2016, according to Eurostat data, obesity affects 10%-30% of adults, and overweight affects 30%-70% adults in European Union countries.
Weight loss with both, prescription-based diet pills and over-the-counter diet pills play a vital role in the treatment of highly critical obesity and diseases associated with it, such as diabetes, hypertension, and sleep apnea.
Cases of obesity among adolescents and children aged 5-19 have grown dramatically from just 4% in 1975 to over 18% in 2016. This shows that prevalence of obesity has nearly tripled between 1975 and 2016.
Thus, rising incidence of obesity and related medical conditions will lead to growing adoption of drugs for weight loss and obesity, which will accelerate demand for weight loss pills.
An Adaptive Approach to Modern-day Research Needs
Why is Demand for Diet Pills Surging across the U.K.?
According to projections by Fact.MR, the market in the U.K. is expected to observe lucrative growth of over the forecast period with a value of approx. US$ 193 Mn by 2031.
In the U.K., around 29% of adults were categorized as obese by the World Health Organization (WHO) in 2017, growing from 26% in 2016. Owing to this, people in the country have increased the consumption of dietary supplements.
Customers here have better access to knowledge about nutrition and health, owing to social media, lifestyle blogs, and active media telecasts. In addition, key players are increasing investments in new product development and advertising, which, consequently, boosts demand for diet pills in the country.
Furthermore, e-Commerce platforms aid market growth at an incredible rate due to the ability to access different brands and for the convenience that it provides.
What Allows Germany to Lead the Diet Suppressants Market in Western Europe?
Sales of diet suppressants in Germany are expected to experience lucrative growth and progress at a CAGR of around 3%. Major factor driving this market is rising concerns about health and increasing deficiency levels in the country.
The German market for diet pills is developing at a steady rate as customers have become more aware about health and are ready to spend on products that are observed as advantageous. Particularly, customers who don’t follow a balanced diet are choosing dietary supplements to the prevent deficiency of essential nutrients.
Also, the trend of self-medication is increasing in Germany due to rising awareness about nutrition deficiency-related disorders and over-the-counter products.
Have a report related query? Speak to us directly
Which Drug Class of Diet Pills Witnesses High Demand in Europe?
Glucomannan accounted for the largest market share of 39.5% in 2020, owing to its effectiveness for appetite suppression.
Glucomannan is a water-soluble, natural dietary fiber extracted from elephant yam roots, called konjac. It absorbs a lot of liquid; a little amount of glucomannan poured to a glass of water turns the total contents into a gel.
These exceptional properties are believed to popularize its use for weight loss. It is different from other soluble fibers, because it is extremely viscous, making it specifically effective for weight loss.
Why is Demand for Herbal Supplements High across Europe?
Herbal diet pills (supplements) represented the largest market share and accounted for a revenue of US$ 444.3 Mn in 2020, prompted by increase in use of organically obtained products.
Herbal supplements are natural supplements added to a diet for enhancing cardiovascular health, immunity, digestion, etc. These products are protective in nature and help prevention of disease rather than concentrating on the cure.
Other dietary supplements include minerals and vitamins (such as multivitamin or a vitamin C). In contrast, herbal supplements are extracted from botanicals (plant and herbs products) and substances that are obtained from a natural source.
How Has COVID-19 Impacted Sales of Diet Pills in the European Market?
In January 2020, the World Health Organization (WHO) declared COVID-19 pandemic as a world health emergency. The pandemic emergency is challenging governments to execute monetary measures and fiscal policies that sustain economic activity and support credit markets.
Because of the COVID-19 pandemic, the diet pills industry in Europe improved among various pockets as maximum of European customers increased their interest on overall wellness and health.
For example, the outbreak of COVID-19 in March 2020 in Poland had a remarkable effect on buying patterns that transformed into volume of product sales. From February to March, the largest sales rise was recorded for products from the health industry, such as OTC drugs, thereby benefiting the dietary supplements market.
Key players are focusing on expansion in emerging countries and introducing features in their product lines. Various manufacturers are spending on developing integrated software that can include cutting-edge technologies to understand the formulation of diet pills.
Market players are also engaged in expanding their regional presence through acquisitions, collaborations, expansions, product launches, and improvement of distribution channels.
- In September 2019, Currax™ Pharmaceuticals LLC announced the acquisition of Nalpropion Pharmaceuticals, Inc. Currax now owns the worldwide rights to CONTRAVE, which is the number one prescribed weight-loss brand medication.
- In June 2020, Holland & Barrett and Deliveroo announced a new partnership to deliver a selected range of more than 200 products from 50 stores across the U.K.
- In September 2018, Nature's Way Products, LLC and Natural Products Canada entered into a new investment agreement for investing in new companies working in natural products sectors such as supplements and dietary ingredients.
Europe Diet Pills Market Report Scope
Historical Data Available for
|USD Million for Value, Volume (Units), Pricing Analysis|
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
|Customization & Pricing||
Available upon Request
Segments Covered Europe Diet Pills Industry Research
- Lipase Inhibitors
- Garcinia Cambogia
- Prescription Drugs
- OTC Drugs
- Herbal Supplements
- Metabolism Raising Diet Pills
- Fat Blocking Diet Pills
- Appetite Controlling Diet Pills
- Diet Pills Sold at Hospital Pharmacies
- Diet Pills Sold at Retail Pharmacies
- Diet Pills Sold at Clinics
- Online Sales of Diet Pills (e-Commerce)
- Sales of Diet Pills by Drug Stores
Europe Diet Pills Market - Scope of Report
The latest publication by Fact.MR on the Europe diet pills market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the Europe diet pills market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the Europe diet pills market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Fact.MR's study. This research study can support readers to know the demand for diet pills in Europe, and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the market, including investors, manufacturers, service providers, distributors, and suppliers, that can help them in developing suitable business strategies to flourish in the market. Insights and data analysis presented in this Fact.MR study can be leveraged by shareholders in the Europe diet pills market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the Europe diet pills market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, with the data submitted in this report, minor companies and new entrants can be aided in making suitable company choices to achieve traction in the market.
Key Questions Answered in Market Report
- Which countries in Europe will continue to remain the most profitable markets for diet pills?
- Which factors will induce a change in the demand for diet pills during the assessment period?
- How will changing trends impact the market?
- How can market players capture the low-hanging opportunities in developed regions?
- What are the winning strategies of stakeholders in the market to upscale their position in this landscape?
- What are the restraints that investors need to be aware of and might tackle while investing in the market?
- What are the developmental trends in Europe diet pills that will impact the market?
- How can businesses avail growth opportunities in developed and emerging sectors?
In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the Europe diet pills market, and reach conclusions on future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to analyse the demand for diet pills include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources are basis of validation from companies in the Europe diet pills market, and makes Fact.MR’s projections on the growth prospects of the market more accurate and reliable.
- FAQs -
The Europe diet pills market is worth US$ 669 Mn at present, on the back of increasing prevalence of obesity, rising health awareness, and growing healthcare expenditure.
Demand for diet pills across Europe is projected to reach a value of US$ 868 Mn by 2031, with glucomannan holding the highest market share.
Historically, the market in Europe progressed at a CAGR of around 1%.
New product launches, mergers and agreements for expansion in emerging markets, rise in healthcare spending, and increasing consumer awareness regarding preventive health are major market trends.
Increasing consumption of diet pills in emerging countries, increasing prevalence of obesity and associated comorbidities, and rising number of manufacturers are complementing market growth.
Top 5 manufacturers of diet pills in Europe hold around 20%-25% market share.
The U.K., Germany, and Italy are the top 3 countries driving demand for diet pills in Europe.
The U.K. market for diet pills is set to exhibit a CAGR of 3.6%, owing to rising e-Commerce platforms and increase in consumption of dietary supplements
The U.K. and Germany are key countries in Europe involved in the manufacturing of diet pills.
After Germany, Italy is the next leading country in Europe and is expected to hold a market share of 14.2% by 2031.
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
The Rise of Intelligent Packaging
Personalized, Connected and Sustainable
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.